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Abstract
Background: The objective of this work was to inform the design of a rapid response program to support
evidence-informed decision-making in health policy and practice for the Americas region. Specifically, we focus
on the following: (1) What are the best methodological approaches for rapid reviews of the research evidence? (2)
What other strategies are needed to facilitate evidence-informed decision-making in health policy and practice?
and (3) How best to operationalize a rapid response program?
Methods: The evidence used to inform the design of a rapid response program included (i) two rapid reviews of
methodological approaches for rapid reviews of the research evidence and strategies to facilitate evidence-
informed decision-making, (ii) supplementary literature in relation to the “shortcuts” that could be considered to
reduce the time needed to complete rapid reviews, (iii) four case studies, and (iv) supplementary literature to
identify additional operational issues for the design of the program.
Results: There is no agreed definition of rapid reviews in the literature and no agreed methodology for conducting
them. Better reporting of rapid review methods is needed. The literature found in relation to shortcuts will be
helpful in choosing shortcuts that maximize timeliness while minimizing the impact on quality. Evidence for other
strategies that can be used concurrently to facilitate the uptake of research evidence, including evidence drawn
from rapid reviews, is presented. Operational issues that need to be considered in designing a rapid response
program include the implications of a “user-pays” model, the importance of recruiting staff with the right mix of
skills and qualifications, and ensuring that the impact of the model on research use in decision-making is formally
evaluated.
Conclusions: When designing a new rapid response program, greater attention needs to be given to specifying
the rapid review methods and reporting these in sufficient detail to allow a quality assessment. It will also be
important to engage in other strategies to facilitate the uptake of the rapid reviews and to evaluate the chosen
model in order to make refinements and add to the evidence base for evidence-informed decision-making.
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Background
While research evidence is only one of many inputs into
decision-making when it comes to health policy [1], it is
important to try to maximize its usefulness and uptake. A
range of programs and efforts already exist to promote the
uptake of research evidence into policy and practice. These
include efforts to conduct systematic reviews of the
evidence (e.g., the Cochrane Collaboration) as well as efforts
to package research evidence, including systematic reviews
to inform policy and practice (e.g., Evidence-Informed Pol-
icy Network (EVIPNet), Health Technology Assessment
agencies). However, while extremely useful, these programs
are often not able to provide access to research quickly nor
answer specific policy questions in a timely way.
There is a wide literature describing the barriers and
facilitators to the consideration of research evidence in
decision-making that can inform the design of a rapid
response program to address this gap [2–6]. The most
frequently reported barriers to evidence uptake are poor
access to good quality relevant research and the lack of
timely and relevant research output [5, 7]. The most
frequently reported facilitators are collaboration between
researchers and policymakers, improved relationships
and skills [5], and research that accords with the beliefs,
values, interests or practical goals, and strategies of
decision-makers [8].
What is a rapid response program and what types of
programs already exist?
A rapid response program that provided rapid reviews of
the results of high-quality research evidence, which was
contextualized and targeted to the needs of decision-
makers, with a fast turn-around time, and that included
interaction between researchers and decision-makers
could overcome some of the barriers and facilitate the
uptake of research into policy and practice.
When describing and designing a “rapid response pro-
gram,” it is important to consider (1) the product offered;
(2) the strategies utilized to facilitate the uptake of the
product into decision-making; and (3) how the program is
operationalized to ensure that it runs smoothly. These
three things together will determine if the rapid response
program meets its intended purpose, i.e., to facilitate the
use of high-quality research in health decision-making.
The number of rapid response programs offering such
a service is increasing [9, 10]. The authors of a recent
study surveyed 29 rapid response programs internation-
ally [10]. Within, and across, these programs, there was
a wide variation in the program objectives, types of
questions answered, and processes and methods used
[10]. The primary objectives for producing rapid reviews
(the main product of rapid response programs) reported
by respondents were to inform decision-making with
regard to funding health care technologies, services, and
policy and program development [10]. The rapid reviews
answered many types of questions—clinical effectiveness
(55.2 %), clinical efficacy (41.4 %), cost-effectiveness and/
or cost savings (41.4 %), and safety (31.0 %)—and were
used to support clinical practice guideline preparation
(17.2 %) for either a health care technology or service.
Some rapid response programs focused exclusively on
questions centered on health system interventions, health
services delivery, health care policy, coverage of a technol-
ogy, operational efficiency, and quality improvement. Two
organizations focused on specific health topics [10].
What are the main products of rapid response programs?
The types of products produced by rapid response pro-
grams are widely varied [10, 11] but were categorized in a
recent study based on the extent of synthesis [11]. Four
product types were described: (1) inventories, which simply
list what evidence is available; (2) rapid responses, which
present the best available evidence but with no formal syn-
thesis; (3) rapid reviews, which synthesize the quality of and
findings from the evidence; and (4) automated approaches,
which generate meta-analyses in response to user-defined
queries [11].
We focused our research on products that include a
synthesis of the evidence because this is the most widely
researched product and most comparable to a standard
systematic review and because we consider it to be the
most useful for increasing the use of research in health
decision-making. This type of rapid product has many
names, including rapid review, evidence summary, brief
review, rapid systematic review, and rapid health tech-
nology assessment. In this paper, we have used the term
“rapid review” as it is the most widely used term in the
published literature [12, 13].
We understand a rapid review to be “a type of system-
atic review in which components of the systematic review
process are simplified, omitted or made more efficient in
order to produce information in a shorter period of time,
preferably with minimal impact on quality. Further, rapid
reviews typically involve a close relationship with the end-
user and are conducted with the needs of the decision-
maker in mind” (Haby MM, Chapman E, Clark R, Barreto
J, Reveiz L, Lavis JN.: What are the best methodologies for
rapid reviews of the research evidence for evidence-
informed decision making in health policy and practice: a
rapid review, submitted).
Objective of this research
The objective of this work was to inform the design of a
rapid response program to support evidence-informed
decision-making in the Americas region. Because the
design of the program could vary depending on the level
of decision-making (e.g., country, state, municipality),
the setting, the resources available (financial and
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workforce), and the needs of decision-makers, we offer
guidance on factors that would need to be taken into ac-
count in setting up a rapid response program in the Amer-
icas region. In practice, the work is also likely to be
relevant to other regions of the world. Specifically, we set
out to answer the following three questions:
1. What are the best methodological approaches for
rapid reviews of the research evidence (the product)?
2. What other strategies are needed to facilitate
evidence-informed decision-making in health policy
and practice?
3. How best to operationalize the program?
Methods
The evidence used to inform the design of a rapid response
program included the following: (i) two rapid reviews of the
best available research evidence (for questions 1 and 2), (ii)
supplementary literature in relation to the “shortcuts” that
could be considered to reduce the time needed to complete
rapid reviews (question 1), and (iii) four case studies and
supplementary literature to identify operational issues for
the design of the program (question 3).
Rapid reviews
We conducted two rapid reviews of the research evidence
to answer the questions:
1. What are the best methodologies to enable a rapid
review of research evidence for evidence-informed
decision-making in health policy and practice?
2. What are the best strategies to facilitate evidence-
informed decision-making in health policy and
practice?
Both reviews utilized systematic review methods and
were conducted according to a pre-defined protocol, in-
cluding clear inclusion criteria [14]. Comprehensive search
strategies were used, including published and gray litera-
ture, written in English, French, Portuguese, or Spanish,
from 2004 onwards. Eleven databases and two websites
were searched. Two review authors independently applied
eligibility criteria. Data extraction was done by one reviewer
and checked by a second reviewer. The methodological
quality of included studies was assessed independently by
two reviewers. A narrative summary of the results is pre-
sented. Full details of the methods, including the inclusion
criteria, can be found in an associated report [15] and
paper (Haby MM, Chapman E, Clark R, Barreto J, Reveiz L,
Lavis JN.: What are the best methodologies for rapid re-
views of the research evidence for evidence-informed deci-
sion making in health policy and practice: a rapid review,
submitted) for question 1 and in Additional files 1 and 2
for question 2. We have labelled these reviews as rapid
reviews because they were conducted in a limited time-
frame and with the needs of the decision-makers in mind.
Identifying supplementary evidence for potential
shortcuts
In relation to areas where “shortcuts” could be considered
to reduce the time needed to complete the rapid reviews,
we used the systematic reviews included in the previously
mentioned review of methodologies of rapid reviews and
the A MeaSurement Tool to Assess systematic Reviews
(AMSTAR) questions [16] to make a list of all possible
areas (shown in column 2, Table 1). To determine the po-
tential impact of the shortcut on the validity of the results,
we used the primary studies included in the reviews by
Ganann and colleagues [17] and Cameron and colleagues
[18] and complemented them with studies cited in the
Cochrane Handbook [19] or found during the search
process for the rapid review. It is important to note that
this was not a systematic search for evidence, though the
majority of the references come from the systematic re-
view by Gannan and colleagues.
Case studies of existing rapid response programs
We developed cases studies of existing rapid response
programs to highlight operational issues that were not
addressed in the systematic reviews included in the review
of methodologies for rapid reviews [9, 17, 18, 20–23]. Case
studies are useful for identifying program processes,
barriers and facilitators and can alert the practitioner
to the existence of otherwise unexplored or unusual
phenomenon [24]. The sampling frame for the selection
of case studies was programs known to the authors
and/or identified during the search process for the two
rapid reviews. To select the four programs for case
studies, we used purposeful sampling to identify four
unique cases [25]. We aimed for maximum variation in
terms of their reach (state level, national, or global) and
stage of development (just starting or long history) and
to ensure representation of both developed and devel-
oping countries. These case studies are not meant to be
representative of all rapid response programs. The four
programs chosen and the main reason/s for their selec-
tion are shown in Table 2.
Case studies were developed based on a structured
interview with a key informant from the program, con-
ducted using Skype. This information was supplemented
with information on the program website and from the
published literature. The questions used in the struc-
tured interview are included in Additional file 3. These
were sent to the key informant prior to the interview.
Key informants were also offered the chance to review
the draft case study before publication. Our first request
for participation was made to the most senior and
knowledgeable representative of the organization offering
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Table 1 Areas where “shortcuts” could be considered to reduce time to completion of rapid reviews
Systematic review
step
Possible “shortcuts” Potential impact on the validity of the results Relevant AMSTAR question and
potential impact of shortcut on
AMSTAR score
Preparation of a
protocol
• Omit protocol Unknown Q1. Loss of one point if a protocol is
not prepared and/or not mentioned
in report
Question formulation • Limit the number of questions and
sub-questions
• Limit the scope of the question/s
None expected
Selecting relevant
studies
• One reviewer screens titles and
abstracts
• One reviewer screens full text
Unknown, though one reviewer could
miss up to 9 % of eligible randomized
controlled trials [42]
Q2. Loss of one point if only one
reviewer does screening and/or only
one reviewer does data extraction
Data extraction • One reviewer extracts data Can increase the number of errors but
the impact on results is not known [43–45]
• One reviewer extracts data with
checking by a second reviewer
Unknown
• Data extraction limited to key
characteristics, results, conflicts of
interest
Unknown
Literature search • Limit number of databases searched
• Limit or omit hand searching of
references lists and relevant journals
• Eliminate consultation with experts
to find additional studies
Limiting the number of databases searched can
increase efficiency without compromising validity
[46–51], especially if combined with some hand
searching and contact with experts [52–57]
Q3. Loss of one point if less than
two databases searched and/or no
supplementary strategies
Inclusion criteria
Gray literature • Limit or omit gray literature Could introduce publication bias but the
evidence is mixed [16, 58–60]
Q4. Loss of one point if gray
literature omitted
Language • English only Effect can vary depending on the question
[50, 61–68]
Dates • Narrow time frame, e.g., last 5 or
10 years
None expected
Study types • Restrict study types to systematic
reviews (and economic evaluations)
• Restrict study types to randomized
controlled trials or controlled clinical
trials (and economic evaluations)
None expected [69–72]
Quality assessment • Limit or omit quality assessment Not recommended. Several authors suggest
that, where resources are limited, priority
should be given to quality assessment rather
than extensive searching [51, 73]
Q7 and Q8. Loss of two points if
not assessed, documented and
used in formulation of conclusions
• Omit “a priori” specification
• Done by one reviewer
Unknown
Data synthesis • Narrative synthesis only
(no meta-analysis)
Unknown – meta-analysis can increase power and
precision but also has potential to mislead if not
applied appropriately and done correctly [19]
Q9. None if explained that
meta-analysis not possible due
to heterogeneity. If not, loss of
one point
Assessment of
publication bias
• Omit Unknown Q10. Loss of one point if omitted
Assessment of conflict
of interest
• Omitted for individual studies
and/or for systematic review
Unknown Q11. Loss of one point if omitted
Report • Information included limited Unknown but can impact on AMSTAR score if
insufficient detail of methods provided to
enable a quality assessment. Sufficient detail of
methods will help the reviewer to assess the
validity of the results [17, 18, 23]
Q1–11. Potential large loss of points
if key AMSTAR questions not
covered
External peer review • Omit or limit Unknown
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the program. In two cases, we were referred to an alterna-
tive knowledgeable contact (McMaster Health Forum and
Cochrane Response).
For one case study (Regional East African Community
Health (REACH) Policy Initiative), the key informant
agreed to participate in the interview but then did not
make any further contact, despite various attempts on
our part, including a request to review the draft case
study. As an alternative, the informant could not be iden-
tified; we decided to develop the case study based on the
information obtained from the published literature [26]
and websites only. All three interviews were conducted in
the first two weeks of June 2015. One key informant (from
the Sax Institute) provided written answers to most of the
questions prior to the interview, and this information was
supplemented in the interview.
The answers to the interview questions were summarized
in a one-page format (see Additional file 3). The general
structure used was a two- to three-paragraph description of
the program, including its scope, who it services, the length
of time it has been operating, governance and operational
arrangements, staffing, products, and process. This was
followed by sections on documents available to guide the
reviews, strengths of the program, challenges, and future
work. The source of information is noted at the end. Where
the program offered more than one product type, we fo-
cused on the product closest to a rapid review. Given the
variation in set-up and conduct of the four programs, it
was not possible to be too prescriptive about how the rele-
vant elements were reported. The draft case study was
checked by the key informant (with the exception of the
REACH Policy Initiative as no response was received from
them) and appropriate revisions made. For Cochrane Inno-
vations, the CEO was also contacted, at the suggestion of
the key informant, to comment on the case study but no
comments were received.
Supplementary literature to inform the design and
operationalization of the program
In the process of conducting the rapid reviews, we identi-
fied a recent study by Hartling and colleagues that provides
information gathered from interviews with key informants
of 20 different rapid response programs [11]. As part of this
study, they describe contextual factors that influenced rapid
review methods. Other insights into how a rapid response
program could be operationalized are presented by Wilson
and colleagues based on findings from an issue brief
and stakeholder dialogue conducted with health system
decision-makers to inform the development of a rapid
response program for Canada [27, 28].
Results
Question 1—methodologies for rapid reviews
Key findings from the rapid review
While five systematic reviews of methods for rapid reviews
were found, none of these were of sufficient quality to
allow firm conclusions to be made. Thus, the findings
need to be treated with caution. There is no agreed defin-
ition of rapid reviews in the literature and no agreed meth-
odology for conducting rapid reviews [9, 17, 18, 20–23].
However, the systematic reviews included in this review
are consistent in stating that a rapid review is generally
conducted in a shorter timeframe and may have a reduced
scope. A wide range of “shortcuts” are used to conduct
rapid reviews more quickly than a full systematic review.
While authors of the included systematic reviews tend to
agree that changes to scope or timeframe can introduce
biases (e.g., selection bias, publication bias, and language
of publication bias), they found little empirical evidence to
support or refute that claim [9, 17, 18, 20, 22]. Further,
there are few comparisons available in the literature of full
and rapid reviews to be able to determine the impact of
these “shortcuts.” There is some evidence from a good
quality randomized controlled trial with low risk of bias
that rapid reviews may improve clarity and accessibility of
research evidence for decision-makers when compared to
a systematic review alone [29].
The included systematic reviews included a variety of
rapid products, including rapid systematic reviews, rapid
health technology assessments, and rapid overviews of
systematic reviews. However, no examples of rapid evi-
dence briefs for policy were included in the reviews.
The authors of the published systematic reviews of
rapid review methods suggest that, rather than focusing
on developing a formalized methodology, which may not
be appropriate, researchers and users should focus on
Table 2 Rapid response programs selected for case studies
Rapid response program Reason for selection References
Cochrane response by Cochrane Innovations,
Cochrane Collaborationa
Has a potential global reach and is supported by the expertise and
experience of the Cochrane Collaboration, though is still in development
McMaster Health Forum Rapid Response Program,
McMaster University, Canada
Comes from a developed country with a strong history in knowledge
translation, potentially national reach
[27, 28, 74]
Regional East African Community Health (REACH)
Policy Initiative, Uganda
Comes from a low-income economy and has a published evaluation [35]
Sax Institute Evidence Check Program, NSW, Australia Has a long history (since 2007) and is a state-level program [75, 76]
aCochrane Innovations is a trading company wholly owned by The Cochrane Collaboration
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increasing the transparency of the methods used for
each review [17, 18, 23]. The authors of the most recent
systematic review also suggest that: “the similarity of
rapid products lies in their close relationship with the
end user to meet decision-making needs in a limited
timeframe” ([9], p. vii).
Key findings from supplementary literature in relation to
‘shortcuts’
The areas where “shortcuts” could be considered to reduce
the time needed to complete the reviews are shown in
Table 1. As can be seen from column 3 of the table, the
supporting literature for the potential impact of shortcuts
in the review process is quite limited and not always
conclusive. It is important to note that not all shortcuts
necessarily lead to a reduction in the AMSTAR score
(e.g., limiting the scope of the review question) and
some shortcuts can have significant implications for the
AMSTAR score but not necessarily save a significant
amount of time (e.g., omitting key methodological details
from the report).
Question 2—strategies to facilitate evidence-informed
decision-making
Key findings from the rapid review
Forty systematic reviews of strategy effectiveness met the
inclusion criteria for this question, of which data were ex-
tracted from 27 of the systematic reviews (see Additional
files 1 and 2). Using the domains of the linking research to
action framework [7, 30], the majority of the interventions
that were evaluated in the included systematic reviews fo-
cused on the practice rather than the policy environments
and, within the former, on “push,” “facilitating pull,” and
“pull” activities. Examples of interventions with significant
impact include dissemination of printed educational
materials, including systematic reviews; clinical librarian
services; education in evidence-based practice; local
opinion leaders; and tailored and targeted messaging
(Additional file 1). For linkage and exchange, knowledge
brokers and interaction between users and producers of
research are the only interventions evaluated but the in-
cluded studies do not provide any evidence of effective-
ness for these interventions.
In regard to rapid reviews, no primary studies of the
effectiveness of strategies to facilitate their uptake were
found by the systematic reviews’ authors. Further, there
are no good quality evaluations of the impact on research
use of packaging of systematic reviews as overviews of sys-
tematic reviews or as evidence briefs based on systematic
reviews [31, 32]. However, there is evidence that dissemin-
ation of printed educational materials [33] and summaries
of systematic reviews [32, 34] are effective at improving
awareness and/or clinical practice (Additional file 1).
Question 3—how best to operationalize the program
Key findings from the case studies
The case studies are presented in Additional file 3. The
models presented in the case studies vary in terms of
when they started, the reach of the service, how the ser-
vice is funded, whether reviews undergo external review,
and whether reviews are made publicly available
(Table 3). Most of the models include a lag period before
publication of the review to allow the commissioning
agency time to prepare for any resulting publicity or to
allow for journal publications to be submitted.
While all programs have some documentation to guide
the process and methods, the actual methods used can
vary between reviews conducted within the same pro-
gram—depending on the question and needs of the re-
questor. The reporting templates used in the models
Table 3 Features of the four rapid response models developed as case studies
Model Started Reach How funded Time to complete
a RR
External
review of RR
RRs made publicly
available
Lag period
before
publication
Cochrane
response
2013 Potentially global Service
Not clear
Reviews
“User-pays”
≈8 weeks (first
review took
12 weeks)
Yes All Yes
McMaster Health
Forum Rapid
Response Program
2012 Potentially national
(Canada)
Service
Ontario government
Reviews
Free in Ontario, “User-pays”
rest of Canada
Max 6 weeks Yes All Yes
REACH Policy
Initiative
2010 National (Uganda) Service and reviews
Donor funds
Max 4 weeks Yes Not reported Not
reported
Sax Institute
Evidence Check
Program
2006 State, potentially
national (Australia)
Service
State government plus
other funds
Reviews
“User-pays”
≈12–16 weeks No Most (some kept
confidential if
requested by funder)
Yes
RR rapid review
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vary in their prescriptiveness but none include minimum
methodological standards or reporting requirements to
enable an accurate quality assessment. For all models, the
process involved in conducting the review requires regular
interaction and communication between researchers
and decision-makers. None of the models have needed
to use priority setting to determine which reviews to
undertake—all reviews that are within the scope of the
service have been accepted.
Each of the models is unique in some way. The
McMaster model is the only one that reported using
other knowledge translation strategies associated with
the conduct of the review, i.e. wide dissemination and
promotion of the completed review, including on social
media, and the offer of a presentation of the review’s
findings to the requestor. The Sax Institute model is the
only one that brokers the reviews out to research groups
selected from their database of researchers or identified
through other means. This model has the advantages of
having researchers with specific expertise in the topic
conduct the review and of building skills in writing for
policy makers in a wider range of researchers. A potential
disadvantage of this approach is the extra work required
by the Sax Institute staff to ensure the review deadlines
are met and to support new researchers (which is cur-
rently done through a one on one informal mentoring
process). The Cochrane Innovations model is unique in
having the support of a large group of highly skilled re-
viewers, though only one review has been conducted to
date. The REACH-PI model is the first known example in
a low-income country and is the only one with some
published evaluation results [35]. Operational issues
highlighted by the key informants or in the published
evaluation [26] that need to be considered by devel-
opers of new programs are reported in Table 4.
Key findings from supplementary literature
In relation to how rapid response programs are opera-
tionalized to ensure that they run smoothly and meet
their intended purpose, the available literature is limited.
The study by Hartling and colleagues describes context-
ual factors that influenced rapid review methods [11].
These were identified by thematic analysis of the inter-
views. Two of these contextual factors related to how
the program was operationalized and are:
 The continuous close relationship with a specific
end user in an iterative fashion throughout the work
to ensure that the product will meet the end user’s
need
 A high reliance on maintaining highly trained staff
to conduct the reviews in a short time frame and
that understand the type of product that might meet
the needs of the decision-maker [11]
Other insights into how a rapid response program
could be operationalized are presented by Wilson and
colleagues based on findings from their issue brief and
stakeholder dialogue [27, 28]. Wilson and colleagues were
unable to find any systematic reviews that addressed how
a rapid review program could be organized. Therefore,
they based their insights on examples of existing rapid re-
view programs [28]. In their issues brief they presented
four organizational features and possible approaches to
operationalizing each feature in Canada. The features
included governance, management and staffing, program
resources, and collaboration [27].
The following suggestions and issues raised by Wilson
and colleagues for a Canadian program warrant consid-
eration in setting up a rapid response program in other
jurisdictions:
Table 4 Operational issues highlighted by the case studies
Issue Description of issue
Contracts and intellectual property If it is a “user-pays” model the use of a contract can slow the process down. However, the impact can be
minimized by operating in good faith and starting the review before the contract is signed (e.g. Cochrane
Innovations, Sax Institute).
Where a contract is used, the intellectual property is usually owned by the funder but there seems to be
general acceptance of joint publication of completed reviews. However, this may not always be the case,
for example, for the Sax Institute model not all reviews are made publicly available if confidentiality is
requested by the funder.
External review of the rapid review External review or “merit review” has the potential to slow the process down if reviewers don’t respond
quickly but the different services all seem to have found ways to manage this well, e.g., approaching
another reviewer if the first one can’t commit to a quick response.
Staffing Recruiting staff with the right mix of skills and qualifications was noted as an issue for the REACH Policy
Initiative model. The other three models used mentoring or internal training to address this issue, with the
Sax Institute key informant noting that the Institute also had plans to develop a formal training program
for researchers.
Evaluation None of the models have formally evaluated the impact of the service on the uptake of research evidence
for policy and/or practice—though there are plans to do this for the McMaster service [27].
Issues particular to developing countries Having a fast and reliable internet connection was noted as an issue for the REACH Policy Initiative model.
Access to databases and full text papers was noted as an issue for the REACH Policy Initiative model.
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 Include high-level representation from all relevant
stakeholders, including policymakers and researchers,
on a steering committee to govern the service
 Implement minimum training standards and provide
ongoing mentorship for staff contributing to the
program
 Funding needs to be long-term and cover both
program delivery and ongoing evaluation of the
program
 Operationalization of the priority setting (if needed)
and administrative process needs to be done at the
institutional level [27, 28]
Two key challenges noted by the stakeholder dialogue
participants when discussing the issues brief included se-
curing stable, long-term funding and finding a way to ef-
fectively and equitably manage the expected demand [27].
Insights for designing a rapid response program for the
Americas region
The product — rapid reviews
The systematic reviews published on this topic advise
against developing a formalized methodology but advo-
cate for greater transparency regarding the methods
used for each review [17, 18, 23]. The four case studies
also showed that current models do not use a formal-
ized, one-size-fits-all methodology. It is likely that this
variation in methodology is due to the differing user re-
quirements. Further, the rapid reviews produced by the
four programs (and available on their website) do not
consistently report clearly and in sufficient detail the
methods used within their reviews to enable an accurate
quality assessment.
None of the included systematic reviews or case studies
explicitly included evidence briefs for policy as a rapid
product. However, rapid reviews produced as part of a
rapid response program could be used to inform evidence
briefs for policy. Also, there is a potential for evidence
briefs for policy to be conducted quickly as part of a rapid
response program. However, the evidence base supporting
this product is limited.
The ideal methods for evidence syntheses continue to
be high quality systematic review methods. Thus, it is
important that the authors of the rapid reviews are
transparent in reporting the methods they used so that
the “shortcuts” taken can be clearly seen and the quality of
the resulting product evaluated. The current, or modified,
PRISMA Guidelines are a good starting point for this [36].
This will also enable researchers to evaluate the impact of
methodological choices on the results of the reviews,
whether rapid or full systematic reviews or overviews of
systematic reviews.
Given that rapid reviews are often (though not always)
written up in a concise fashion to meet the needs of
busy decision-makers, a checklist could be developed
that lists the key aspects of systematic review methodology
and requires a simple tick or cross to indicate whether or
not it was done (e.g., two reviewers screened titles and ab-
stracts). For some aspects, a short answer would be appro-
priate, e.g., which databases were searched. Table 1 will be
a very useful reference for this. If preferred, the methods
section could be included at the end of the review, as an
appendix to the review or placed online. Further, it is ap-
propriate to evaluate rapid reviews using the same criteria
as systematic reviews, e.g., using the AMSTAR criteria
[16], which will also allow better comparisons with sys-
tematic reviews on issues of validity of the results. We
suggest that the AMSTAR criteria could be used to assess
the quality of reviews of systematic reviews (also known as
overviews) as well as reviews of primary studies.
It is possible that the greater the number of “shortcuts”
that are taken to reduce the time needed to complete the
review the greater the risk that biases will be introduced.
Therefore, an appropriate balance needs to be found be-
tween quality and timeliness when deciding what methods
to use, whether a rapid (vs full systematic) review is
needed and how quickly it really is needed.
Consideration also needs to be given to which “short-
cuts” are taken to ensure maximum quality. Some short-
cuts may be seen as more important by users in terms of
their perceived impact on risk of bias of the results. We
suggest that omission of the quality assessment of in-
cluded studies could be one such shortcut, as implied by
participants’ ranking of six rapid review approaches in
the study by Tricco and colleagues [13, Table 5], where
the top ranked approach included a quality assessment.
Its omission will also lead to a loss of two points on the
AMSTAR score (Table 1). In contrast, limiting the number
of databases searched to to to three and only including the
last 10 years of literature may have limited impact on per-
ceived risk of bias for many topics and no impact on the
AMSTAR score.
As well as the shortcuts identified in Table 1, other ap-
proaches exist that can be used to make a rapid review
faster than a systematic review. These should not have
an impact on the validity of the results and include [20]:
 Making the process more efficient, e.g., using
specialized software for the reviews such as
DistillerSR®
 Using a larger, highly skilled staff, who are part of a
reserve capacity
 Updating an existing high quality review
Strategies to facilitate evidence-informed decision-making
Given that there is no support for the effectiveness of
rapid reviews alone in promoting the uptake of research
evidence into policy and practice (Additional file 1), it
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will be extremely important to also engage concurrently
in other knowledge translation strategies as part of the
model. Examples include the use of tailored and targeted
messaging in the rapid reviews, dissemination of the
rapid reviews, and training of policy makers in the ap-
praisal and use of research (Additional file 1). It will also
be important to evaluate the impact of these strategies
to improve the evidence base for future decision-making
regarding the design of rapid response programs.
It is important to remember that rapid reviews are typ-
ically conducted at the request of a decision-maker and
the decision-maker has an important involvement in set-
ting the question, the parameters of the review and the
timeline. They may also provide feedback along the way.
And unlike traditional systematic reviews, they are usu-
ally written with the context of the decision-maker in
mind, e.g., the policy or practice question that needs an
answer [9]. We suggest that these features are likely to
increase the chance that the rapid reviews are utilized in
decision-making but this needs to be tested.
Operationalization of the rapid response program
In regard to the organizational arrangements for the rapid
response program, consideration will need to be given to
the issues raised in other related literature presented in
this paper [11, 27, 28] (see the “Results, Question 3—how
best to operationalize the program” section) or in the case
studies (Table 4).
Discussion
The research presented in this paper will help to inform
the design of a rapid response program for health policy
and practice that can be applied to the Americas region.
The rapid review of methodologies for rapid reviews and
additional evidence found in relation to shortcuts that
could be considered to reduce the time needed to
complete the reviews (Table 1) are relevant to the design
of the main product of the rapid response program—the
rapid review. The rapid review of strategies to facilitate
evidence-informed decision-making found a number of
strategies that had a significant impact and which could
be incorporated into the program. Finally, the case stud-
ies of four current models of rapid response identified
additional operational issues that need to be considered
in designing new programs (Table 4), as did the supple-
mentary literature [11, 27, 28].
Implications for future research
Priority for future research should be given to research
into the effect of shortcuts on the conclusions of reviews
in general (rapid and systematic)—thus filling the gaps
in Table 1, column 3. Further, we suggest that research
that compares the conclusions of systematic reviews and
rapid reviews for the same topic, controlling for review
quality, should also be prioritized.
We agree with Polisena and colleagues that the impact
of rapid reviews used to inform health decision-making
should be tested, as should the feasibility and desire for
an extension to the PRISMA guidelines to incorporate
rapid review methodologies, including different types of
reports needed [10]. We suggest that the content of re-
vised PRISMA guidelines should be heavily based on the
current guidelines but allow for different ways to present
the information, including in appendices or using check-
lists. They should also focus on aspects that are not rou-
tinely part of systematic reviews, such as the extent of
involvement of the review funders in the conduct of the
review as this could impact on quality (e.g., potential
conflict of interest) but could also facilitate the use of
the rapid review in decision-making.
Current reviews of rapid review programs suggest that
one of the defining features of rapid reviews (and other
rapid products) is the close relationship with the end
user [9], with personal contact between researchers and
decision-makers being a known facilitator of the uptake
of evidence [2, 5, 37]. The process can also potentially
build skills [5] and trust [37] between researchers and
decision-makers. Research is required to identify which
elements of this relationship increase the use of the review
in decision-making (if they do). This research should also
be extended to test the impact of these strategies in in-
creasing the uptake of research in general, including sys-
tematic reviews, in decision-making.
Strengths and limitations
A key strength of this research was the use of high qual-
ity systematic review methods to guide the development
of a rapid response program as well as case studies and
further literature searching to help fill knowledge gaps.
The case studies were able to verify the large variation
in existing programs [9–11, 13, 18, 23] and identify op-
erational issues that had not been previously identified.
A limitation of our research is the small number of case
studies included, but this was supplemented with the
findings of more comprehensive surveys of current rapid
response programs [9–11, 13] (see the “Background”
section) and other relevant work in this area [27, 28].
Another possible limitation of our research and insights
offered for a rapid response program is the reliance on
AMSTAR for assessing and comparing the quality of rapid
reviews and systematic reviews. AMSTAR was created to
assess the quality of systematic reviews of randomized
controlled trials, and thus, it could be argued that it is not
appropriate for other types of reviews, e.g., reviews of
reviews, reviews of non-randomized studies, and realist
reviews. At the present time, however, the AMSTAR
tool is the best tool available to our knowledge to assess
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and compare the quality of review methods for reviews
of effectiveness and considers the major potential sources
for bias in reviews of the literature [16, 38]. As other tools
are developed and more widely used, such as RAMESES
for realist reviews [39], variations of AMSTAR for non-
randomized studies [40], and the new ROBIS tool to assess
the risk of bias in systematic reviews [41], they can also be
used for rapid response programs to assess the quality of
their products.
Conclusions
There is no one clear method or process for rapid response
suggested by the research evidence found in the rapid re-
views, related literature, or case studies—and a variety of
approaches may be needed. The ideal methods for evidence
synthesis continue to be high quality systematic review
methods. However, the literature, and our experience, tells
us that policy and practice decisions need to be made and
cannot always wait until the best evidence is available. In
these cases, there is a very real risk that no research evi-
dence or poor quality research evidence will be used. Thus,
it is better that researchers try to accommodate the needs
of busy decision-makers by producing rapid reviews that
optimally balance timeliness and quality and, where
possible, to evaluate later how the results differ from
full reviews. In this paper, we have highlighted factors
that need to be taken into account in setting up a rapid
response program. We also advocate for greater atten-
tion to be given to the reporting of methods used in
rapid reviews to allow a quality assessment. Finally, it
will be important to evaluate the rapid response programs
chosen model in order to make refinements and to add to
the evidence base for evidence-informed decision-making.
Additional files
Additional file 1: What are the best strategies to facilitate evidence-
informed decision-making: a rapid overview of systematic reviews.
(DOCX 323 kb)
Additional file 2: Appendices to the rapid overview of strategies to
facilitate evidence-informed decision-making. (DOCX 187 kb)
Additional file 3: Case studies. (DOCX 40 kb)
Acknowledgements
We thank the key informants of the case studies for making time to do the
interview and to check the completed case studies for accuracy: Chantelle
Garritty for Cochrane Response; Mike Wilson for McMaster Rapid Response;
and Sian Rudge for Sax Institute Evidence Check.
Funding
This work was developed and funded under the cooperation agreement #
47 between the Department of Science and Technology of the Ministry of
Health of Brazil and the Pan American Health Organization. The funders of
this study set the terms of reference for the project but, apart from the input
of JB, EC, and LR to the conduct of the study, did not significantly influence
the work. Manuscript preparation was funded by the Ministry of Health
Brazil, through an EVIPNet Brazil project with the Bireme/PAHO.
Authors’ contributions
EC and JB had the original idea for the research and obtained funding; MH
was responsible for developing the case studies and analysis of other
relevant literature and drafted the manuscript; EC and JB contributed to the
development of questions and selection of programs for the case studies; all
authors contributed ideas to, provided commentary on, and approved the
final manuscript.
Competing interests
Neither the Ministry of Health of Brazil nor the Pan American Health
Organization (PAHO) has a vested interest in this research—though they do
have a professional interest in increasing the uptake of research evidence in
decision making. Two of the review authors (EC and LR) are employees of
PAHO and JB was an employee of the Ministry of Health of Brazil at the time
of the study. However, the views and opinions expressed herein are those of
the overview authors and do not necessarily reflect the views of the Ministry
of Health of Brazil or the Pan American Health Organization. In relation to
the case studies, MH, as part of her previous employment with an Australian
state government Department of Health, was responsible for commissioning
and using rapid reviews to inform decision making and has commissioned
rapid reviews from the Sax Institute Evidence Check program. JNL has had
some involvement with all four rapid response programs that were used in
the case studies but did not participate in the selection or conduct of the
case studies. The authors declare that they have no competing interests.
Author details
1Department of Chemical and Biological Sciences, Universidad de Sonora,
Hermosillo, Sonora, México. 2Centre for Health Policy, Melbourne School of
Population and Global Health, The University of Melbourne, Victoria,
Australia. 3Pan American Health Organization, Brasilia, DF, Brazil. 4Centre of
Excellence in Intervention and Prevention Science, Melbourne, Australia.
5Fundação Oswaldo Cruz, Diretoria de Brasília, Brazil. 6Knowledge
Management, Bioethics and Research, Pan American Health Organization,
Washington, DC, USA. 7McMaster Health Forum, Centre for Health Economics
and Policy Analysis, Department of Clinical Epidemiology and Biostatistics,
and Department of Political Science, McMaster University, Hamilton, Canada.
8Department of Global Health and Population Boston, Harvard T.H. Chan
School of Public Health, Boston, MA, USA.
Received: 25 December 2015 Accepted: 15 July 2016
References
1. Wiseman J. Chapter 1. Lost in translation: knowledge, policy, politics and
power. In: Carey G, Landvogt K, Barraket J, editors. Creating and
implementing public policy: cross-sectoral debates. London: Routledge,
Taylor and Francis Group; 2015. Policy Press.
2. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards
systematic reviews that inform health care management and policy-making.
J Health Serv Res Policy. 2005;10 Suppl 1:35–48.
3. Liverani M, Hawkins B, Parkhurst JO. Political and institutional influences on
the use of evidence in public health policy. A systematic review. PLoS One.
2013;8:e77404.
4. Nutley S. Bridging the policy/research divide. Reflections and lessons from
the UK. Keynote paper presented at “Facing the future: Engaging stakeholders
and citizens in developing public policy”. National Institute of Governance
Conference, Canberra, Australia 23/24 April 2003. http://www.treasury.govt.nz/
publications/media-speeches/guestlectures/nutley-apr03. 2003. Accessed 19
Jul 2016
5. Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review of
barriers to and facilitators of the use of evidence by policymakers. BMC
Health Serv Res. 2014;14:2.
6. Orton L, Lloyd-Williams F, Taylor-Robinson D, O’Flaherty M, Capewell S. The
use of research evidence in public health decision making processes:
systematic review. PLoS One. 2011;6:e21704.
7. WHO. Knowledge translation framework for ageing and health. Geneva:
Department of Ageing and Life-Course, World Health Organization; 2012.
8. Lavis JN, Hammill AC, Gildiner A, McDonagh RJ, Wilson MG, Ross SE, et al. A
systematic review of the factors that influence the use of research evidence
by public policymakers. Final report submitted to the Canadian Population
Haby et al. Implementation Science  (2016) 11:117 Page 10 of 12
Health Initiative. Hamilton: McMaster University Program in Policy Decision-
Making; 2005.
9. Hartling L, Guise JM, Kato E, Anderson J, Aronson N, Belinson S, et al. EPC
Methods: An Exploration of Methods and Context for the Production of
Rapid Reviews. Rockville: AHRQ Publication No. 15-EHC008-EF; 2015.
Research White Paper. (Prepared by the Scientific Resource Center under
Contract No. 290-2012-00004-C.).
10. Polisena J, Garrity C, Kamel C, Stevens A, Abou-Setta AM. Rapid review
programs to support health care and policy decision making: a descriptive
analysis of processes and methods. Syst Rev. 2015;4:26.
11. Hartling L, Guise JM, Kato E, Anderson J, Belinson S, Berliner E, et al. A
taxonomy of rapid reviews links report types and methods to specific
decision-making contexts. J Clin Epidemiol. 2015;68:1451–62.
12. Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, et al. A scoping
review of rapid review methods. BMC Med. 2015;13:224.
13. Tricco AC, Zarin W, Antony J, Hutton B, Moher D, Sherifali D, et al. An
international survey and modified Delphi approach revealed numerous
rapid review methods. J Clin Epidemiol. 2015;70:61–7.
14. Haby M, Chapman E, Reveiz L, Barreto J, Clark R. Methodologies for rapid
response for evidence-informed decision making in health policy and
practice: an overview of systematic reviews and primary studies (Protocol).
2015. PROSPERO: CRD42015015998.
15. Haby MM, Chapman E, Reveiz L, Barreto J, Clark R, Lavis JN. Methodologies
for rapid response for evidence-informed decision making in health policy
and practice: a rapid overview. Report submitted to the World Health
Organization, Brazil. 2015.
16. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al.
Development of AMSTAR: a measurement tool to assess the methodological
quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
17. Ganann R, Ciliska D, Thomas H. Expediting systematic reviews: methods and
implications of rapid reviews. Implement Sci. 2010;5:56.
18. Cameron A, Watt A, Lathlean T, Sturm L. Rapid versus full systematic
reviews: an inventory of current methods and practice in Health
Technology Assessment. ASERNIP-S Report No. 60. Adelaide: ASERNIP-S,
Royal Australasian College of Surgeons; 2007.
19. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of
interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration;
2011. Available from http://handbook.cochrane.org/ Accessed 19 Jul 2016.
20. Abrami PC, Borokhovski E, Bernard RM, Wade CA, Tamim R, Persson T, et al.
Issues in conducting and disseminating brief reviews of evidence. Evid
Policy. 2010;6:371–89.
21. Featherstone RM, Dryden DM, Foisy M, Guise JM, Mitchell MD, Paynter RA,
et al. Advancing knowledge of rapid reviews: an analysis of results,
conclusions and recommendations from published review articles
examining rapid reviews. Syst Rev. 2015;4:50.
22. Harker J, Kleijnen J. What is a rapid review? A methodological exploration of
rapid reviews in Health Technology Assessments. Int J Evid Based Healthc.
2012;10:397–410.
23. Watt A, Cameron A, Sturm L, Lathlean T, Babidge W, Blamey S, et al. Rapid
reviews versus full systematic reviews: an inventory of current methods and
practice in health technology assessment. Int J Technol Assess Health Care.
2008;24:133–9.
24. Daly J, Willis K, Small R, Green J, Welch N, Kealy M, et al. A hierarchy of evidence
for assessing qualitative health research. J Clin Epidemiol. 2007;60:43–9.
25. Patton MQ. Qualitative research and evaluation methods: integrating theory
and practice. 4th ed. Los Angeles: Sage Publications; 2015. 806.
26. Mijumbi RM, Oxman AD, Panisset U, Sewankambo NK. Feasibility of a rapid
response mechanism to meet policymakers inverted question mark urgent
needs for research evidence about health systems in a low income country:
a case study. Implement Sci. 2014;9:114.
27. Wilson MG, Lavis JN, Gauvin FP. Developing a rapid-response program for
health system decision-makers in Canada: findings from an issue brief and
stakeholder dialogue. Syst Rev. 2015;4:25.
28. Wilson MG, Lavis JN, Gauvin FP. Issue brief: developing a ‘rapid-response’
program for health system decision-makers in Canada. Hamilton: McMaster
Health Forum; 2014. 7 March 2014.
29. Opiyo N, Shepperd S, Musila N, Allen E, Nyamai R, Fretheim A, et al. Comparison
of alternative evidence summary and presentation formats in clinical guideline
development: a mixed-method study. PLoS One. 2013;8:e55067.
30. Lavis JN, Lomas J, Hamid M, Sewankambo NK. Assessing country-level
efforts to link research to action. Bull World Health Organ. 2006;84:620–8.
31. Chambers D, Wilson PM, Thompson CA, Hanbury A, Farley K, Light K.
Maximizing the impact of systematic reviews in health care decision
making: a systematic scoping review of knowledge-translation resources.
Milbank Q. 2011;89:131–56.
32. Murthy L, Shepperd S, Clarke MJ, Garner SE, Lavis JN, Perrier L, et al.
Interventions to improve the use of systematic reviews in decision-making
by health system managers, policy makers and clinicians. Cochrane
Database Syst Rev. 2012;Issue 9:Art. No. CD009401.
33. Giguere A, Legare F, Grimshaw J, Turcotte S, Fiander M, Grudniewicz A,
et al. Printed educational materials: effects on professional practice and
healthcare outcomes. Cochrane Database Syst Rev. 2012;Issue 10:Art. No.
CD004398.
34. Wallace J, Byrne C, Clarke M. Improving the uptake of systematic reviews: a
systematic review of intervention effectiveness and relevance. BMJ Open.
2014;4:e005834.
35. Mijumbi RM, Oxman AD, Panisset U, Sewankambo NK. Feasibility of a rapid
response mechanism to meet policymakers’ urgent needs for research
evidence about health systems in a low income country: a case study.
Implement Sci. 2014;9:114.
36. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA statement.
PLoS Med. 2009;6:e1000097.
37. Innvaer S, Vist G, Trommald M, Oxman A. Health policy-makers’ perceptions
of their use of evidence: a systematic review. J Health Serv Res Policy.
2002;7:239–44.
38. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, et al.
AMSTAR is a reliable and valid measurement tool to assess the methodological
quality of systematic reviews. J Clin Epidemiol. 2009;62:1013–20.
39. Wong G, Greenhalgh T, Westhrop G, Pawson R. Quality standards for realist
syntheses and meta-narrative reviews. London: Nuffield Department of
Primary Care Health Sciences, University of Oxford. http://www.
ramesesproject.org/Standards_and_Training_materials.php.
40. Shea B. AMSTAR - Developments Ottawa, Canada: AMSTAR; 2015. Accessed
7 Jul 2016. Available from: http://amstar.ca/Developments.php. Accessed 19
Jul 2016.
41. Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al.
ROBIS: a new tool to assess risk of bias in systematic reviews was
developed. J Clin Epidemiol. 2016;69:225–34.
42. Edwards P, Clarke M, DiGuiseppi C, Pratap S, Roberts I, Wentz R.
Identification of randomized controlled trials in systematic reviews: accuracy
and reliability of screening records. Stat Med. 2002;21:1635–40.
43. Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP. Single data
extraction generated more errors than double data extraction in systematic
reviews. J Clin Epidemiol. 2006;59:697–703.
44. Gotzsche PC, Hrobjartsson A, Maric K, Tendal B. Data extraction errors in
meta-analyses that use standardized mean differences. JAMA. 2007;298:430–7.
45. Jones AP, Remmington T, Williamson PR, Ashby D, Smyth RL. High
prevalence but low impact of data extraction and reporting errors were
found in Cochrane systematic reviews. J Clin Epidemiol. 2005;58:741–2.
46. Royle P, Milne R. Literature searching for randomized controlled trials used
in Cochrane reviews: rapid versus exhaustive searches. Int J Technol Assess
Health Care. 2003;19:591–603.
47. Sampson M, Barrowman NJ, Moher D, Klassen TP, Pham B, Platt R, et al.
Should meta-analysts search Embase in addition to Medline? J Clin
Epidemiol. 2003;56:943–55.
48. Royle P, Waugh N. Literature searching for clinical and cost-effectiveness
studies used in health technology assessment reports carried out for the
National Institute for Clinical Excellence appraisal system. Health Technol
Assess. 2003;7:iii. ix-x, 1-51.
49. Topfer LA, Parada A, Menon D, Noorani H, Perras C, Serra-Prat M.
Comparison of literature searches on quality and costs for health
technology assessment using the MEDLINE and EMBASE databases. Int J
Technol Assess Health Care. 1999;15:297–303.
50. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are
comprehensive literature searches and the assessment of trial quality in
systematic reviews? Empirical study. Health Technol Assess. 2003;7:1–76.
51. Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research
evidence in guideline development: 8. Synthesis and presentation of
evidence. Health Res Policy Syst. 2006;4:20.
52. Doust JA, Pietrzak E, Sanders S, Glasziou PP. Identifying studies for
systematic reviews of diagnostic tests was difficult due to the poor
Haby et al. Implementation Science  (2016) 11:117 Page 11 of 12
sensitivity and precision of methodologic filters and the lack of information
in the abstract. J Clin Epidemiol. 2005;58:444–9.
53. Gartlehner G, West SL, Lohr KN, Kahwati L, Johnson JG, Harris RP, et al.
Assessing the need to update prevention guidelines: a comparison of two
methods. Int J Qual Health Care. 2004;16:399–406.
54. Hopewell S, Clarke M, Lefebvre C, Scherer R. Handsearching versus
electronic searching to identify reports of randomized trials. Cochrane
Database Syst Rev. 2007;Issue 2:Art. No. MR000001.
55. Langham J, Thompson E, Rowan K. Identification of randomized controlled
trials from the emergency medicine literature: comparison of hand
searching versus MEDLINE searching. Ann Emerg Med. 1999;34:25–34.
56. McManus RJ, Wilson S, Delaney BC, Fitzmaurice DA, Hyde CJ, Tobias RS,
et al. Review of the usefulness of contacting other experts when
conducting a literature search for systematic reviews. BMJ. 1998;317:1562–3.
57. Savoie I, Helmer D, Green CJ, Kazanjian A. Beyond Medline: reducing bias
through extended systematic review search. Int J Technol Assess Health
Care. 2003;19:168–78.
58. Hopewell S, McDonald S, Clarke M, Egger M. Grey literature in meta-
analyses of randomized trials of health care interventions. Cochrane
Database Syst Rev. 2007;Issue 2:Art. No. MR000010.
59. McAuley L, Pham B, Tugwell P, Moher D. Does the inclusion of grey
literature influence estimates of intervention effectiveness reported in
meta-analyses? Lancet. 2000;356:1228–31.
60. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-
analysis: power of statistical tests and prevalence in the literature. J Clin
Epidemiol. 2000;53:1119–29.
61. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G.
Language bias in randomised controlled trials published in English and
German. Lancet. 1997;350:326–9.
62. Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR, et al. What
contributions do languages other than English make on the results of
meta-analyses? J Clin Epidemiol. 2000;53:964–72.
63. Moher D, Pham B, Lawson ML, Klassen TP. The inclusion of reports of
randomised trials published in languages other than English in systematic
reviews. Health Technol Assess. 2003;7:1–90.
64. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of
language bias in meta-analyses of controlled trials: empirical study. Int J
Epidemiol. 2002;31:115–23.
65. Lawson ML, Pham B, Klassen TP, Moher D. Systematic reviews involving
complementary and alternative medicine interventions had higher quality of
reporting than conventional medicine reviews. J Clin Epidemiol. 2005;58:777–84.
66. Pham B, Klassen TP, Lawson ML, Moher D. Language of publication
restrictions in systematic reviews gave different results depending on
whether the intervention was conventional or complementary. J Clin
Epidemiol. 2005;58:769–76.
67. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, et al.
Completeness of reporting of trials published in languages other than
English: implications for conduct and reporting of systematic reviews.
Lancet. 1996;347:363–6.
68. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only
positive results? A systematic review of controlled trials. Control Clin Trials.
1998;19:159–66.
69. Becker LA, Oxman AD. Chapter 22: Overviews of reviews. In: Higgins JPT,
Green S, editors. Cochrane handbook for systematic reviews of interventions
version 5.1.0 (updated March 2011) Available from http://handbook.
cochrane.org/: The Cochrane Collaboration; 2011. Accessed 19 Jul 2016.
70. The Joanna Briggs Institute. Joanna Briggs Institute reviewers’ manual: 2014
edition/supplement. Adelaide: The Joanna Briggs Institute; 2014.
71. Lee E, Dobbins M, Decorby K, McRae L, Tirilis D, Husson H. An optimal
search filter for retrieving systematic reviews and meta-analyses. BMC Med
Res Methodol. 2012;12:51.
72. Westphal A, Kriston L, Holzel LP, Harter M, von Wolff A. Efficiency and
contribution of strategies for finding randomized controlled trials: a case
study from a systematic review on therapeutic interventions of chronic
depression. J Public Health Res. 2014;3:177.
73. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the
quality of controlled clinical trials. BMJ. 2001;323:42–6.
74. Wilson MG, Lavis JN, Gauvin FP. Dialogue summary: developing a ‘rapid-
response’ program for health system decision-makers in Canada. Hamilton:
McMaster Health Forum; 2014. 7 March 2014.
75. Campbell D, Donald B, Moore G, Frew D. Evidence check: knowledge brokering
to commission research reviews for policy. Evid Policy. 2011;7:97–107.
76. Redman S, Jorm L, Haines M. Increasing the use of research in health policy:
the Sax Institute model. Australas Epidemiol. 2008;15:15–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Haby et al. Implementation Science  (2016) 11:117 Page 12 of 12
